At DCAT With Piramal Pharma Solutions
Peter DeYoung, CEO, Piramal Pharma Solutions, talks about recent company achievements and key offerings, as well as current industry trends.
At a recent Drug, Chemical & Associated Technologies (DCAT) conference, Pharmaceutical Technology spoke with Peter DeYoung, CEO, Piramal Pharma Solutions, to learn more about the company's offerings. Watch to learn more about:
- Piramal's key service offerings and integrated solutions in the areas of oncology and ADCs.
- The current operating environment for CDMOs and industry trends.
- Piramal's strategy to expand its territorial footprint in the US beyond its existing facilities.
Recent Videos
Related Content
How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)
November 29th 2022Podcast
Allison Labriola, Senior Technical Sales Representative, at JRS Pharma is interviewed by the Editorial Director of Pharmaceutical Technology Chris Spivey about how the food industry is affecting the pharmaceutical industry.
